List view / Grid view
17 March 2016 | By Caroline Richards
Caroline Richards, Editor of Drug Target Review, invites Michael Springer, Associate Professor of Systems Biology, Harvard Medical School to discuss a laboratory study of a yeast model using microfluidic systems...
17 March 2016 | By Merck KGaA
The CellASIC® ONIX2 Microfluidic System for live cell imaging is easy to use and gives researchers precise environmental control over live cells. By providing dynamic control over drug addition, gas, temperature, media and more, this all in one system is the perfect addition to your microscope to enhance your imaging…
Microfluidic technology has great potential for complementing and, in some instances, replacing the use of animal models in the testing of medicines and in developing personalised treatments for cancer patients.
18 February 2016 | By SELECTBIO
SELECTBIO is delighted to announce Organ-on-a-Chip Europe 2016, which will be held on 5 - 6 April in Cambridge, UK...
Simple Plex assays run on Ella™ enabled simultaneous quantitation of four analytes from eight samples in a disposable cartridge in under an hour...
Microfluidic miniaturisation, or the so-called ‘lab-on-a-chip’ concept, now encroaches on the fields of biology, medicine and pharmacology, and the nature of microfluidic technology (small volumes and high-throughput integration of fluid connections) means that it is outperforming conventional bench work. There has been an incredible need for microfluidic technology in the…
The recent developments in microfluidic technology have provided an effective microreactor platform for the production of a range of pharmaceutically related materials in both nano- and micro-scale. This can be attributed to the unique characteristics that microfluidic-based reactors offer in terms of controllability and uniformity of the material characteristics, compared…
